Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.64 |
| ▸ | PKM | P14618 | 1/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.64 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | F2 | P00734 | 5/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | CTSK | P43235 | 1/20 | 0.52 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8543317 | 0.92 | F2 (0.58) | CYP3A4CYP2C9PKMCYP2C19F2 | |
| SCHEMBL8548845 | 0.90 | F2 (0.56) | CYP3A4CYP2C9PKMCYP2C19F2 | |
| SCHEMBL8544635 | 0.89 | ALDH1A1 (0.64) | CYP3A4CYP2C9PKMCYP2C19F2 | |
| SCHEMBL8543073 | 0.89 | F2 (0.56) | CYP3A4CYP2C9PKMCYP2C19F2 | |
| SCHEMBL8545019 | 0.89 | F2 (0.56) | CYP3A4CYP2C9PKMCYP2C19F2 | |
| SCHEMBL8549486 | 0.88 | ALDH1A1 (0.56) | CYP3A4CYP2C9PKMCYP2C19F2 | |
| SCHEMBL8544897 | 0.87 | CYP3A4 (0.57) | CYP3A4CYP2C9PKMCYP2C19NPC1 | |
| SCHEMBL8544624 | 0.87 | PTGER4 (0.57) | CYP3A4CYP2C9PKMCYP2C19F2 | |
| SCHEMBL8548694 | 0.85 | PTGER4 (0.66) | CYP3A4CYP2C9PKMCYP2C19F2 | |
| SCHEMBL8549094 | 0.85 | F2 (0.52) | CYP3A4CYP2C9PKMCYP2C19F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0564924-B1 | 2-Oxoethyl derivatives as immunosuppressants | BAYER AG (US) | 1998-09-09 | — | — | EP | claimed |
| EP-0564924-A2 | 2-Oxoethyl derivatives as immunosuppressants | Bayer Corporation (US) | 1993-10-13 | — | — | EP | claimed |
| EP-0564924-B1 | 2-Oxoethyl derivatives as immunosuppressants | BAYER AG (US) | 1998-09-09 | — | — | EP | disclosed |
| EP-0564924-A2 | 2-Oxoethyl derivatives as immunosuppressants | Bayer Corporation (US) | 1993-10-13 | — | — | EP | disclosed |